Position in NTLA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,990,187
+$1,239,129 QoQ
Shares Held
176,725
+29.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 330 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. NTLA ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in NTLA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,990,187 | 176,725 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,751,058 | 136,588 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,190,860 | 132,465 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,754,202 | 159,479 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,540,627 | 164,246 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,115,118 | 156,838 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,938,451 | 166,248 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,344,491 | 162,749 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,923,997 | 175,335 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,581,460 | 166,538 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,980,785 | 163,358 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,185,205 | 163,985 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,622,957 | 162,407 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,508,915 | 147,811 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,033,859 | 144,278 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,153,366 | 127,830 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,188,425 | 119,560 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,139,609 | 98,247 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,306,936 | 95,627 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,251,605 | 98,782 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,942,791 | 98,467 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,786,420 | 97,021 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $5,550,758 | 102,036 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,946,788 | 97,927 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,928,353 | 91,739 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $924,979 | 75,632 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||